|
1
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stockwell BR, Friedmann Angeli JP, Bayir
H, Bush AI, Conrad M, Dixon SJ, Fulda S, Gascón S, Hatzios SK,
Kagan VE, et al: Ferroptosis: A regulated cell death nexus linking
metabolism, redox biology, and disease. Cell. 171:273–285. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jiang L, Kon N, Li T, Wang SJ, Su T,
Hibshoosh H, Baer R and Gu W: Ferroptosis as a p53-mediated
activity during tumour suppression. Nature. 520:57–62. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Y, Shi J, Liu X, Feng L, Gong Z,
Koppula P, Sirohi K, Li X, Wei Y, Lee H, et al: BAP1 links
metabolic regulation of ferroptosis to tumour suppression. Nat Cell
Biol. 20:1181–1192. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gao M, Yi J, Zhu J, Minikes AM, Monian P,
Thompson CB and Jiang X: Role of mitochondria in ferroptosis. Mol
Cell. 73:354–363. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lei G, Zhuang L and Gan B: Targeting
ferroptosis as a vulnerability in cancer. Nat Rev Cancer.
22:381–396. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fonseca-Nunes A, Jakszyn P and Agudo A:
Iron and cancer risk-a systematic review and meta-analysis of the
epidemiological evidence. Cancer Epidemiol Biomarkers Prev.
23:12–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo Q, Li L, Hou S, Yuan Z, Li C, Zhang W,
Zheng L and Li X: The Role of Iron in Cancer Progression. Front
Oncol. 10:7784922021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh
HJ III, Kang R and Tang D: Autophagy promotes ferroptosis by
degradation of ferritin. Autophagy. 12:1425–1428. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Q, Han X, Lan X, Gao Y, Wan J, Durham
F, Cheng T, Yang J, Wang Z, Jiang C, et al: Inhibition of neuronal
ferroptosis protects hemorrhagic brain. JCI Insight. 2:e907772017.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang C, Liu X, Jin S, Chen Y and Guo R:
Ferroptosis in cancer therapy: A novel approach to reversing drug
resistance. Mol Cancer. 21:472022. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Richardson DR and Ponka P: The molecular
mechanisms of the metabolism and transport of iron in normal and
neoplastic cells. Biochimica et biophysica acta. 1331:1–40. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brown CW, Amante JJ, Chhoy P, Elaimy AL,
Liu H, Zhu LJ, Baer CE, Dixon SJ and Mercurio AM: Prominin2 drives
ferroptosis resistance by stimulating iron export. Dev Cell.
51:575–586.e4. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen X, Kang R, Kroemer G and Tang D:
Broadening horizons: The role of ferroptosis in cancer. Nat Rev
Clin Oncol. 18:280–296. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang WS, Kim KJ, Gaschler MM, Patel M,
Shchepinov MS and Stockwell BR: Peroxidation of polyunsaturated
fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci
USA. 113:E4966–E4975. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao M, Monian P, Pan Q, Zhang W, Xiang J
and Jiang X: Ferroptosis is an autophagic cell death process. Cell
Res. 26:1021–1032. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kremer DM, Nelson BS, Lin L, Yarosz EL,
Halbrook CJ, Kerk SA, Sajjakulnukit P, Myers A, Thurston G, Hou SW,
et al: GOT1 inhibition promotes pancreatic cancer cell death by
ferroptosis. Nat Commun. 12:48602021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim EH, Shin D, Lee J, Jung AR and Roh JL:
CISD2 inhibition overcomes resistance to sulfasalazine-induced
ferroptotic cell death in head and neck cancer. Cancer Lett.
432:180–190. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Alvarez SW, Sviderskiy VO, Terzi EM,
Papagiannakopoulos T, Moreira AL, Adams S, Sabatini DM, Birsoy K
and Possemato R: NFS1 undergoes positive selection in lung tumours
and protects cells from ferroptosis. Nature. 551:639–643. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu T, Xiao Z, Yuan H, Tian H, Chen T,
Chen Q, Chen M, Yang J, Zhou Q, Guo W, et al: ACO1 and IREB2
downregulation confer poor prognosis and correlate with
autophagy-related ferroptosis and immune infiltration in KIRC.
Front Oncol. 12:929838. 2022.
|
|
21
|
Jiang X, Stockwell BR and Conrad M:
Ferroptosis: Mechanisms, biology and role in disease. Nat Rev Mol
Cell Biol. 22:266–282. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Porter NA, Caldwell SE and Mills KA:
Mechanisms of free radical oxidation of unsaturated lipids. Lipids.
30:277–290. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shah R, Shchepinov MS and Pratt DA:
Resolving the role of lipoxygenases in the initiation and execution
of ferroptosis. ACS Cent Sci. 4:387–396. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ghosh MK, Mukhopadhyay M and Chatterjee
IB: NADPH-initiated cytochrome P450-dependent free iron-independent
microsomal lipid peroxidation: Specific prevention by ascorbic
acid. Mol Cell Biochem. 166:35–44. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zou Y, Li H, Graham ET, Deik AA, Eaton JK,
Wang W, Sandoval-Gomez G, Clish CB, Doench JG and Schreiber SL:
Cytochrome P450 oxidoreductase contributes to phospholipid
peroxidation in ferroptosis. Nat Chem Biol. 16:302–309. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Doll S, Proneth B, Tyurina YY, Panzilius
E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A,
et al: ACSL4 dictates ferroptosis sensitivity by shaping cellular
lipid composition. Nat Chem Biol. 13:91–98. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dixon SJ, Winter GE, Musavi LS, Lee ED,
Snijder B, Rebsamen M, Superti-Furga G and Stockwell BR: Human
haploid cell genetics reveals roles for lipid metabolism genes in
nonapoptotic cell death. ACS Chem Biol. 10:1604–1609. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J,
Zhong M, Yuan H, Zhang L, Billiar TR, et al: The tumor suppressor
p53 limits ferroptosis by blocking DPP4 activity. Cell Rep.
20:1692–1704. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yang WH, Huang Z, Wu J, Ding CC, Murphy SK
and Chi JT: A TAZ-ANGPTL4-NOX2 axis regulates ferroptotic cell
death and chemoresistance in epithelial ovarian cancer. Mol Cancer
Res. 18:79–90. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Y, Ran Q, Duan Q, Jin J, Wang Y, Yu L,
Wang C, Zhu Z, Chen X and Weng L: 7-Dehydrocholesterol dictates
ferroptosis sensitivity. Nature. 626:411–418. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Maiorino M, Scapin M, Ursini F, Biasolo M,
Bosello V and Flohé L: Distinct promoters determine alternative
transcription of gpx-4 into phospholipid-hydroperoxide glutathione
peroxidase variants. J Biol Chem. 278:34286–34290. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yant LJ, Ran Q, Rao L, Van Remmen H,
Shibatani T, Belter JG, Motta L, Richardson A and Prolla TA: The
selenoprotein GPX4 is essential for mouse development and protects
from radiation and oxidative damage insults. Free Radic Biol Med.
34:496–502. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee
H, Koppula P, Wu S, Zhuang L, Fang B, et al: DHODH-mediated
ferroptosis defence is a targetable vulnerability in cancer.
Nature. 593:586–590. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu J, Liu M, Zhang H, Wei X, Wang J, Xian
M and Guo W: Exploring cysteine regulation in cancer cell survival
with a highly specific ‘Lock and Key’ fluorescent probe for
cysteine. Chem Sci. 10:10065–10071. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Roh JL, Kim EH, Jang HJ, Park JY and Shin
D: Induction of ferroptotic cell death for overcoming cisplatin
resistance of head and neck cancer. Cancer Lett. 381:96–103. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ingold I, Berndt C, Schmitt S, Doll S,
Poschmann G, Buday K, Roveri A, Peng X, Porto Freitas F, Seibt T,
et al: Selenium utilization by GPX4 is required to prevent
Hydroperoxide-Induced ferroptosis. Cell. 172:409–422.e21. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Seiler A, Schneider M, Förster H, Roth S,
Wirth EK, Culmsee C, Plesnila N, Kremmer E, Rådmark O, Wurst W, et
al: Glutathione peroxidase 4 senses and translates oxidative stress
into 12/15-lipoxygenase dependent- and AIF-mediated cell death.
Cell Metab. 8:237–248. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cui S, Ghai A, Deng Y, Li S, Zhang R,
Egbulefu C, Liang G, Achilefu S and Ye J: Identification of
hyperoxidized PRDX3 as a ferroptosis marker reveals ferroptotic
damage in chronic liver diseases. Mol Cell. 83:3931–3939.e5. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Floros KV, Chawla AT, Johnson-Berro MO,
Khatri R, Stamatouli AM, Boikos SA, Dozmorov MG, Cowart LA and
Faber AC: MYCN upregulates the transsulfuration pathway to suppress
the ferroptotic vulnerability in MYCN-amplified neuroblastoma. Cell
Stress. 6:21–29. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu D, Liang CH, Huang B, Zhuang X, Cui W,
Yang L, Yang Y, Zhang Y, Fu X, Zhang X, et al: Tryptophan
metabolism acts as a new anti-ferroptotic pathway to mediate tumor
growth. Adv Sci (Weinh). 10:e22040062023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wu M, Xu LG, Li X, Zhai Z and Shu HB:
AMID, an apoptosis-inducing factor-homologous
mitochondrion-associated protein, induces caspase-independent
apoptosis. J Biol Chem. 277:25617–25623. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Doll S, FreitasF P, Shah R, Aldrovandi M,
da Silva MC, Ingold I, Goya Grocin A, Xavier da Silva TN, Panzilius
E, Scheel CH, et al: FSP1 is a glutathione-independent ferroptosis
suppressor. Nature. 575:693–698. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Frei B, Kim MC and Ames BN: Ubiquinol-10
is an effective lipid-soluble antioxidant at physiological
concentrations. Proc Natl Acad Sci USA. 87:4879–4883. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Turunen M, Olsson J and Dallner G:
Metabolism and function of coenzyme Q. Biochim Biophys Acta.
1660:171–199. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Takahashi T, Okamoto T, Mori K, Sayo H and
Kishi T: Distribution of ubiquinone and ubiquinol homologues in rat
tissues and subcellular fractions. Lipids. 28:803–809. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Bersuker K, Hendricks JM, Li Z, Magtanong
L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, et al:
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit
ferroptosis. Nature. 575:688–692. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Vasan K, Werner M and Chandel NS:
Mitochondrial metabolism as a target for cancer therapy. Cell
Metab. 32:341–352. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Thöny B, Auerbach G and Blau N:
Tetrahydrobiopterin biosynthesis, regeneration and functions.
Biochem J. 347:1–16. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Soula M, Weber RA, Zilka O, Alwaseem H, La
K, Yen F, Molina H, Garcia-Bermudez J, Pratt DA and Birsoy K:
Metabolic determinants of cancer cell sensitivity to canonical
ferroptosis inducers. Nat Chem Biol. 16:1351–1360. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Werner ER, Blau N and Thöny B:
Tetrahydrobiopterin: Biochemistry and pathophysiology. Biochem J.
438:397–414. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kraft VAN, Bezjian CT, Pfeiffer S,
Ringelstetter L, Müller C, Zandkarimi F, Merl-Pham J, Bao X,
Anastasov N, Kössl J, et al: GTP Cyclohydrolase
1/Tetrahydrobiopterin counteract ferroptosis through lipid
remodeling. ACS Cent Sci. 6:41–53. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Kagan VE, Mao G, Qu F, Angeli JP, Doll S,
Croix CS, Dar HH, Liu B, Tyurin VA, Ritov VB, et al: Oxidized
arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem
Biol. 13:81–90. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Liang D, Feng Y, Zandkarimi F, Wang H,
Zhang Z, Kim J, Cai Y, Gu W, Stockwell BR and Jiang X: Ferroptosis
surveillance independent of GPX4 and differentially regulated by
sex hormones. Cell. 186:2748–2764.e22. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kaiser AM and Attardi LD: Deconstructing
networks of p53-mediated tumor suppression in vivo. Cell Death
Differ. 25:93–103. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Bykov VJN, Eriksson SE, Bianchi J and
Wiman KG: Targeting mutant p53 for efficient cancer therapy. Nat
Rev Cancer. 18:89–102. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wang Y, Yang L, Zhang X, Cui W, Liu Y, Sun
QR, He Q, Zhao S, Zhang GA, Wang Y, et al: Epigenetic regulation of
ferroptosis by H2B monoubiquitination and p53. EMBO Rep.
20:e475632019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Thomas T and Thomas TJ: Polyamine
metabolism and cancer. J Cell Mol Med. 7:113–126. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Mandal S, Mandal A and Park MH: Depletion
of the polyamines spermidine and spermine by overexpression of
spermidine/spermine N¹-acetyltransferase 1 (SAT1) leads to
mitochondria-mediated apoptosis in mammalian cells. Biochem J.
468:435–447. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ou Y, Wang SJ, Li D, Chu B and Gu W:
Activation of SAT1 engages polyamine metabolism with p53-mediated
ferroptotic responses. Proc Natl Acad Sci USA. 113:E6806–E6812.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Abbas T and Dutta A: p21 in cancer:
Intricate networks and multiple activities. Nat Rev Cancer.
9:400–414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Hu W, Zhang C, Wu R, Sun Y, Levine A and
Feng Z: Glutaminase 2, a novel p53 target gene regulating energy
metabolism and antioxidant function. Proc Natl Acad Sci USA.
107:7455–7460. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R
and Tang D: Activation of the p62-Keap1-NRF2 pathway protects
against ferroptosis in hepatocellular carcinoma cells. Hepatology.
63:173–184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Fan Z, Wirth AK, Chen D, Wruck CJ, Rauh M,
Buchfelder M and Savaskan N: Nrf2-Keap1 pathway promotes cell
proliferation and diminishes ferroptosis. Oncogenesis. 6:e3712017.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Chan JY and Kwong M: Impaired expression
of glutathione synthetic enzyme genes in mice with targeted
deletion of the Nrf2 basic-leucine zipper protein. Biochim Biophys
Acta. 1517:19–26. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Lu J, Zhao Y, Liu M, Lu J and Guan S:
Toward improved human health: Nrf2 plays a critical role in
regulating ferroptosis. Food Funct. 12:9583–9606. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Lu C, Xu W, Zhang F, Shao J and Zheng S:
Nrf2 knockdown disrupts the protective effect of curcumin on
alcohol-induced hepatocyte necroptosis. Mol Pharm. 13:4043–4053.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Anandhan A, Dodson M, Schmidlin CJ, Liu P
and Zhang DD: Breakdown of an ironclad defense system: The critical
role of NRF2 in mediating ferroptosis. Cell Chem Biol. 27:436–447.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ryan MB and Corcoran RB: Therapeutic
strategies to target RAS-mutant cancers. Nat Rev Clin Oncol.
15:709–720. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Dolma S, Lessnick SL, Hahn WC and
Stockwell BR: Identification of genotype-selective antitumor agents
using synthetic lethal chemical screening in engineered human tumor
cells. Cancer Cell. 3:285–296. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Yang WS and Stockwell BR: Synthetic lethal
screening identifies compounds activating iron-dependent,
nonapoptotic cell death in oncogenic-RAS-harboring cancer cells.
Chem Biol. 15:234–245. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Dai E, Han L, Liu J, Xie Y, Kroemer G,
Klionsky DJ, Zeh HJ, Kang R, Wang J and Tang D: Autophagy-dependent
ferroptosis drives tumor-associated macrophage polarization via
release and uptake of oncogenic KRAS protein. Autophagy.
16:2069–2083. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Singhal R, Mitta SR, Das NK, Kerk SA,
Sajjakulnukit P, Solanki S, Andren A, Kumar R, Olive KP, Banerjee
R, et al: HIF-2α activation potentiates oxidative cell death in
colorectal cancers by increasing cellular iron. J Clin Invest.
131:e1436912021. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Keith B, Johnson RS and Simon MC: HIF1α
and HIF2α: Sibling rivalry in hypoxic tumour growth and
progression. Nat Rev Cancer. 12:9–22. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Li Z, Jiang L, Chew SH, Hirayama T, Sekido
Y and Toyokuni S: Carbonic anhydrase 9 confers resistance to
ferroptosis/apoptosis in malignant mesothelioma under hypoxia.
Redox Biol. 26:1012972019. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Yang M, Chen P, Liu J, Zhu S, Kroemer G,
Klionsky DJ, Lotze MT, Zeh HJ, Kang R and Tang D: Clockophagy is a
novel selective autophagy process favoring ferroptosis. Sci Adv.
5:eaaw22382019. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zou Y, Palte MJ, Deik AA, Li H, Eaton JK,
Wang W, Tseng YY, Deasy R, Kost-Alimova M, Dančík V, et al: A
GPX4-dependent cancer cell state underlies the clear-cell
morphology and confers sensitivity to ferroptosis. Nat Commun.
10:16172019. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wang M, Mao C, Ouyang L, Liu Y, Lai W, Liu
N, Shi Y, Chen L, Xiao D, Yu F, et al: Long noncoding RNA LINC00336
inhibits ferroptosis in lung cancer by functioning as a competing
endogenous RNA. Cell Death Differ. 26:2329–2343. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Wang Z, Chen X, Liu N, Shi Y, Liu Y,
Ouyang L, Tam S, Xiao D, Liu S, Wen F, et al: A nuclear long
Non-Coding RNA LINC00618 accelerates ferroptosis in a manner
dependent upon apoptosis. Mol Ther. 29:263–274. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhang K, Wu L, Zhang P, Luo M, Du J, Gao
T, O'Connell D, Wang G, Wang H and Yang Y: miR-9 regulates
ferroptosis by targeting glutamic-oxaloacetic transaminase GOT1 in
melanoma. Mol Carcinog. 57:1566–1576. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Luo M, Wu L, Zhang K, Wang H, Zhang T,
Gutierrez L, O'Connell D, Zhang P, Li Y, Gao T, et al: miR-137
regulates ferroptosis by targeting glutamine transporter SLC1A5 in
melanoma. Cell Death Differ. 25:1457–1472. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Kryczka J, Kryczka J, Czarnecka-Chrebelska
KH and Brzeziańska-Lasota E: Molecular mechanisms of
chemoresistance induced by cisplatin in NSCLC cancer therapy. Int J
Mol Sci. 22:88852021. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Galluzzi L, Senovilla L, Vitale I, Michels
J, Martins I, Kepp O, Castedo M and Kroemer G: Molecular mechanisms
of cisplatin resistance. Oncogene. 31:1869–1883. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Gai C, Yu M, Li Z, Wang Y, Ding D, Zheng
J, Lv S, Zhang W and Li W: Acetaminophen sensitizing
erastin-induced ferroptosis via modulation of Nrf2/heme oxygenase-1
signaling pathway in non-small-cell lung cancer. J Cell Physiol.
235:3329–3339. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Li Y, Yan H, Xu X, Liu H, Wu C and Zhao L:
Erastin/sorafenib induces cisplatin-resistant non-small cell lung
cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway.
Oncol Lett. 19:323–333. 2020.PubMed/NCBI
|
|
86
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Gu R, Xia Y, Li P, Zou D, Lu K, Ren L,
Zhang H and Sun Z: Ferroptosis and its role in gastric cancer.
Front Cell Dev Biol. 10:8603442020. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv
L, Liu J, Xu Y, Shen Y and Yang M: Noncoding RNAs in gastric
cancer: Implications for drug resistance. Mol Cancer. 19:622020.
View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Cai S, Fu S, Zhang W, Yuan X, Cheng Y and
Fang J: SIRT6 silencing overcomes resistance to sorafenib by
promoting ferroptosis in gastric cancer. Biochem Biophys Res
Commun. 577:158–164. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Xu X and Li Y, Wu Y, Wang M, Lu Y, Fang Z,
Wang H and Li Y: Increased ATF2 expression predicts poor prognosis
and inhibits sorafenib-induced ferroptosis in gastric cancer. Redox
Biol. 59:1025642023. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Zhang H, Deng T, Liu R, Ning T, Yang H,
Liu D, Zhang Q, Lin D, Ge S, Bai M, et al: CAF secreted miR-522
suppresses ferroptosis and promotes acquired chemo-resistance in
gastric cancer. Mol Cancer. 19:432020. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Waks AG and Winer EP: Breast cancer
treatment: A Review. JAMA. 321:288–300. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Gentles AJ, Newman AM, Liu CL, Bratman SV,
Feng W, Kim D, Nair VS, Xu Y, Khuong A, Hoang CD, et al: The
prognostic landscape of genes and infiltrating immune cells across
human cancers. Nat Med. 21:938–945. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Kim IS, Gao Y, Welte T, Wang H, Liu J,
Janghorban M, Sheng K, Niu Y, Goldstein A, Zhao N, et al:
Immuno-subtyping of breast cancer reveals distinct myeloid cell
profiles and immunotherapy resistance mechanisms. Nat Cell Biol.
21:1113–1126. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Lu X and Lu X: Enhancing immune checkpoint
blockade therapy of genitourinary malignancies by co-targeting
PMN-MDSCs. Biochim Biophys Acta Rev Cancer. 1877:1887022022.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Zhao Y, Liu Z, Liu G, Zhang Y, Liu S, Gan
D, Chang W, Peng X, Sung ES, Gilbert K, et al: Neutrophils resist
ferroptosis and promote breast cancer metastasis through aconitate
decarboxylase 1. Cell Metab. 35:1688–1703.e10. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Louandre C, Marcq I, Bouhlal H, Lachaier
E, Godin C, Saidak Z, François C, Chatelain D, Debuysscher V,
Barbare JC, et al: The retinoblastoma (Rb) protein regulates
ferroptosis induced by sorafenib in human hepatocellular carcinoma
cells. Cancer Lett. 356:971–977. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Hu X, He Y, Han Z, Liu W, Liu D, Zhang X,
Chen L, Qi L, Chen L, Luo Y, et al: PNO1 inhibits
autophagy-mediated ferroptosis by GSH metabolic reprogramming in
hepatocellular carcinoma. Cell Death Dis. 13:10102022. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Koppula P, Zhuang L and Gan B: Cystine
transporter SLC7A11/xCT in cancer: Ferroptosis, nutrient
dependency, and cancer therapy. Protein Cell. 12:599–620. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Shimada K, Hayano M, Pagano NC and
Stockwell BR: Cell-line selectivity improves the predictive power
of pharmacogenomic analyses and helps identify NADPH as biomarker
for ferroptosis sensitivity. Cell Chem Biol. 23:225–235. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Wang H, An P, Xie E, Wu Q, Fang X, Gao H,
Zhang Z, Li Y, Wang X, Zhang J, et al: Characterization of
ferroptosis in murine models of hemochromatosis. Hepatology.
66:449–465. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Fang X, Zhang J, Li Y, Song Y, Yu Y, Cai
Z, Lian F, Yang J, Min J and Wang F: Malic Enzyme 1 as a novel
Anti-Ferroptotic regulator in hepatic Ischemia/Reperfusion injury.
Adv Sci (Weinh). 10:e22054362023. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Tang J, Long G, Hu K, Xiao D, Liu S, Xiao
L, Zhou L and Tao Y: Targeting USP8 Inhibits O-GlcNAcylation of
SLC7A11 to promote ferroptosis of hepatocellular carcinoma via
stabilization of OGT. Adv Sci (Weinh). 10:e23029532023. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Lheureux S, Gourley C, Vergote I and Oza
AM: Epithelial ovarian cancer. Lancet. 393:1240–1253. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Yao Y, Wang B, Jiang Y, Guo H and Li Y:
The mechanisms crosstalk and therapeutic opportunities between
ferroptosis and ovary diseases. Front Endocrinol (Lausanne).
14:11940892023. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Cheng Q, Bao L, Li M, Chang K and Yi X:
Erastin synergizes with cisplatin via ferroptosis to inhibit
ovarian cancer growth in vitro and in vivo. J Obstet Gynaecol Res.
47:2481–2491. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Hong T, Lei G, Chen X, Li H, Zhang X, Wu
N, Zhao Y, Zhang Y and Wang J: PARP inhibition promotes ferroptosis
via repressing SLC7A11 and synergizes with ferroptosis inducers in
BRCA-proficient ovarian cancer. Redox Biol. 42:1019282021.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Ma LL, Liang L, Zhou D and Wang SW: Tumor
suppressor miR-424-5p abrogates ferroptosis in ovarian cancer
through targeting ACSL4. Neoplasma. 68:165–173. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Igal RA: Stearoyl CoA desaturase-1: New
insights into a central regulator of cancer metabolism. Biochim
Biophys Acta. 1861:1865–1880. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Tesfay L, Paul BT, Konstorum A, Deng Z,
Cox AO, Lee J, Furdui CM, Hegde P, Torti FM and Torti SV:
Stearoyl-CoA Desaturase 1 protects ovarian cancer cells from
ferroptotic cell death. Cancer Res. 79:5355–5366. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Hsiao C, Lampe M, Nillasithanukroh S, Han
W, Lian X and Palecek SP: Human pluripotent stem cell culture
density modulates YAP signaling. Biotechnol J. 11:662–675. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Yang WH, Lin CC, Wu J, Chao PY, Chen K,
Chen PH and Chi JT: The hippo pathway effector YAP promotes
ferroptosis via the E3 ligase SKP2. Mol Cancer Re. 19:1005–1014.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Li HW, Liu MB, Jiang X, Song T, Feng SX,
Wu JY, Deng PF and Wang XY: GALNT14 regulates ferroptosis and
apoptosis of ovarian cancer through the EGFR/mTOR pathway. Future
Oncol. 18:149–161. 2022. View Article : Google Scholar : PubMed/NCBI
|
